Hans-Peter Gerber

Company: 3T Biosciences

Job title: SVP & CSO

Seminars:

Identification of Novel pHLA Targets for Solid Tumor Targeting with High Potency Modalities 4:00 pm

Advantages of intracellular targets (pHLAs) versus conventional cell surface antigens Strategies to find the most prevalent and immunogenic targets in tumors of CPI responders Selection of pHLA targets with highest tumor vs normal ratios to avoid off-tumor toxicitiesRead more

day: Day One

Industry Leaders Fireside Chat – What Does the Future Hold for TCR therapies? 10:30 am

The hotly anticipated Industry Leader’s Fireside Chat will discuss the huge progress being made in the TCR therapeutic space. This session will explore the lessons we can takes from CAR-T, and will shed clarity on the priorities of the trailblazing companies in this field, whilst also touching upon the challenges faced with manufacturing costs, and…Read more

day: Day One